Janine Stutterheim

9PUBLICATIONS
72CO-AUTHORS
Peripheral nervous systemHaematological tumoursGene and molecular therapyPredictive and prognostic markersLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 18, 2025
Minimal Residual Disease Detection in Peripheral Blood of Patients With High-Risk Neuroblastoma Correlates With Outcome in the International GPOH-DCOG Prospective Validation Study.

Nina U Gelineau, Lieke M J van Zogchel, Boris De Carolis

|Oct 01, 2025
Infant acute lymphoblastic leukaemia-Progress from worldwide clinical efforts.

Neil Barrett, Tanja A Gruber, Takako Miyamura

|Sep 10, 2024
Are measurable residual disease results after consolidation therapy useful in children with acute lymphoblastic leukemia?

Janine Stutterheim, Rachella van der Waarden, Hester A de Groot-Kruseman

|Aug 23, 2024
Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the international community.

Branko Cuglievan, Hagop Kantarjian, Jeffrey E Rubnitz

|Jun 19, 2024
Distinct Responses to Menin Inhibition and Synergy with DOT1L Inhibition in KMT2A-Rearranged Acute Lymphoblastic and Myeloid Leukemia.

Fabienne R S Adriaanse, Pauline Schneider, Susan T C J M Arentsen-Peters

|Jan 18, 2023
Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Pediatric Rhabdomyosarcoma.

Nathalie S M Lak, Lieke M J van Zogchel, Lily Zappeij-Kannegieter

Pageof 2

Frequent Collaborators

3 joint publications

Godelieve A M Tytgat

3 joint publications

Lieke M J van Zogchel

3 joint publications

Nathalie S M Lak

3 joint publications

Lily Zappeij-Kannengieter